Alembic Pharmaceuticals Ltd (APLLTD) — Announcement | 11 September 2026

11 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Company completes unannounced USFDA bioequivalence inspection with no observations

💡 Investor Takeaway

The successful inspection validates the company's manufacturing quality systems, reducing regulatory risk for future US product launches.

Alembic Pharmaceuticals announced the successful completion of an unannounced USFDA onsite bioequivalence inspection at its Vadodara facility with no Form 483 observations, covering the period from August 31 to September 10, 2026. This regulatory milestone reinforces the company's compliance standing ahead of potential product approvals.

📄 View Original Announcement (PDF)

📊 Stock Analysis — APLLTD ✨ Ask AI About This

About Alembic Pharmaceuticals Ltd (APLLTD)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹16,790.42 CrP/E: 24.2ROE: 12.2%ROCE: 11.7%Div Yield: 1.40%

View full APLLTD stock details →

📡 Get AI alerts when APLLTD files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APLLTD — Free

💡 Ask AI about this filing

"How does this inspection impact Alembic's pending US generic drug applications?""What is the timeline for potential revenue from products linked to this facility?""How does this compare to competitors' recent FDA inspection outcomes?"

Ask AI Free →

📊 More APLLTD filings

Announcement — 28 September 2026Alembic Pharmaceuticals announced that its trading window will close on October 1, 2026, and remain ...
🔴 Announcement — 18 September 2026Alembic Pharmaceuticals announced one-to-one investor and analyst meetings in Mumbai on September 23...
🔴 Announcement — 16 September 2026Alembic Pharmaceuticals announced that the USFDA closed its inspection of the Vadodara bioequivalenc...
🔴 Announcement — 7 September 2026Alembic Pharmaceuticals announced the incorporation of its wholly owned subsidiary, Alembic Pharmace...
🔴 Announcement — 27 August 2026Alembic Pharmaceuticals announced a series of one-on-one investor and analyst meetings scheduled for...

See all APLLTD filings →

🔥 Also filed on 11 September 2026

MONEYBOXXMoneyboxx Finance LtdInsider Trading ADANIPORTSAdani Ports & Special Economic Zone LtdAnnouncement 517170Edvenswa Enterprises LtdAnnouncement GLENMARKGlenmark Pharmaceuticals LtdAnnouncement SIGMAADVSigma Advanced System LtdAnnouncement GLENMARKGlenmark Pharmaceuticals LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when APLLTD files new disclosures

Track APLLTD filings, board meetings, and corporate actions. Free email alerts at 5 PM.